AMI key facts
as of Oct 2026- Operator of a medical innovation business intended to change auscultation and enable accessible, non-invasive cardiac assessment anytime and anywhere.
- AMI is valued at approximately $40.1M as of Oct 2026 (last reported valuation).
- It has raised $21.5M; the latest was Later Stage VC ($6.0M) in May 2025.
- Notable investors include MedTech Innovator, SBI Investment, Japan External Trade Organization, UntroD, Development Bank of Japan — 25 tracked in total.
- Status: Privately Held (backing).
AMI's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 25 names
- ·Watch AMI: the Monday email on marks, rounds and moves
AMI funding rounds
No funding rounds for AMI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs AMI
25+AMI valuation
AMI's last reported valuation was $40.1 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
AMI investors
25 investors are on record for AMI, including MedTech Innovator, SBI Investment, Japan External Trade Organization and UntroD.
About AMI
Operator of a medical innovation business intended to change auscultation and enable accessible, non-invasive cardiac assessment anytime and anywhere. The company offers proprietary medical hardware, simultaneous acquisition of heart sounds and electrocardiograms, machine learning-based diagnostic support, and remote data sharing capabilities, enabling healthcare professionals and medical institutions to support task shifting and telemedicine with improved cardiac insight and clinical decision support.
- Sector
- Healthcare
- HQ
- Kagoshima, Japan
- Founded
- 2015
- Employees
- 43
- Website
- ami.inc/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.